QCM
RVMD icon

Quantinno Capital Management’s Revolution Medicines RVMD Stock Holding History

Quantinno Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
76,743
+13,383
+21% +$1.95M 0.02% 834
2026
Q1 		$6.16M Buy
63,360
+31,297
+98% +$3.16M 0.01% 1054
2025
Q4 		$2.55M Buy
32,063
+7,348
+30% +$482K 0.01% 1282
2025
Q3 		$1.15M Buy
+24,715
New +$968K ﹤0.01% 1418

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Quantinno Capital Management's RVMD Position: Q2 2026 in Review

Quantinno Capital Management increased its Revolution Medicines (RVMD) stake by 21% in Q2 2026, buying an estimated $1.95M and bringing the position to 76,743 shares worth $14.4M. The position accounts for 0.02% of the portfolio, ranked #834.

Quantinno Capital Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Quantinno Capital Management held 76,743 shares of Revolution Medicines worth $14.4M as of Q2 2026.
  • Quantinno Capital Management bought 13,383 Revolution Medicines shares in Q2 2026, an estimated $1.95M.
  • Revolution Medicines made up 0.02% of Quantinno Capital Management's portfolio in Q2 2026, its #834 holding.
  • Quantinno Capital Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.